Karamouzis MV - Search Results

1

Updates on the treatment of invasive breast cancer: Quo Vadimus?

Nigdelis MP, Karamouzis MV, Kontos M, Alexandrou A, Goulis DG, Lambrinoudaki I. Nigdelis MP, et al. Among authors: karamouzis mv. Maturitas. 2021 Mar;145:64-72. doi: 10.1016/j.maturitas.2020.11.006. Epub 2020 Nov 26. Maturitas. 2021. PMID: 33541565 Review.

2

Breast cancer: the upgraded role of HER-3 and HER-4.

Karamouzis MV, Badra FA, Papavassiliou AG. Karamouzis MV, et al. Int J Biochem Cell Biol. 2007;39(5):851-6. doi: 10.1016/j.biocel.2006.11.017. Epub 2006 Dec 27. Int J Biochem Cell Biol. 2007. PMID: 17254832 Review.

3

DNA repair pathways and their implication in cancer treatment.

Pallis AG, Karamouzis MV. Pallis AG, et al. Among authors: karamouzis mv. Cancer Metastasis Rev. 2010 Dec;29(4):677-85. doi: 10.1007/s10555-010-9258-8. Cancer Metastasis Rev. 2010. PMID: 20821251 Review.

4

Transcription factor networks as targets for therapeutic intervention of cancer: the breast cancer paradigm.

Karamouzis MV, Papavassiliou AG. Karamouzis MV, et al. Mol Med. 2011;17(11-12):1133-6. doi: 10.2119/molmed.2011.00315. Epub 2011 Sep 6. Mol Med. 2011. PMID: 21912809 Free PMC article. Review.

5

Targeting insulin-like growth factor in breast cancer therapeutics.

Karamouzis MV, Papavassiliou AG. Karamouzis MV, et al. Crit Rev Oncol Hematol. 2012 Oct;84(1):8-17. doi: 10.1016/j.critrevonc.2012.02.010. Epub 2012 Mar 15. Crit Rev Oncol Hematol. 2012. PMID: 22424863 Review.

6

Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?

Anestis A, Karamouzis MV, Dalagiorgou G, Papavassiliou AG. Anestis A, et al. Among authors: karamouzis mv. Cancer Treat Rev. 2015 Jun;41(6):547-53. doi: 10.1016/j.ctrv.2015.04.009. Epub 2015 Apr 29. Cancer Treat Rev. 2015. PMID: 25944485 Review.

7

HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas.

Karamouzis MV, Dalagiorgou G, Georgopoulou U, Nonni A, Kontos M, Papavassiliou AG. Karamouzis MV, et al. Oncotarget. 2016 Feb 2;7(5):5576-97. doi: 10.18632/oncotarget.6762. Oncotarget. 2016. PMID: 26716646 Free PMC article.

8

Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights.

Anestis A, Zoi I, Papavassiliou AG, Karamouzis MV. Anestis A, et al. Among authors: karamouzis mv. Molecules. 2020 Jan 15;25(2):358. doi: 10.3390/molecules25020358. Molecules. 2020. PMID: 31952272 Free PMC article. Review.

9

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL.

Simatou A, Sarantis P, Koustas E, Papavassiliou AG, Karamouzis MV. Simatou A, et al. Among authors: karamouzis mv. Int J Mol Sci. 2020 Oct 14;21(20):7570. doi: 10.3390/ijms21207570. Int J Mol Sci. 2020. PMID: 33066388 Free PMC article. Review.

10

Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules.

Vallilas C, Sarantis P, Kyriazoglou A, Koustas E, Theocharis S, Papavassiliou AG, Karamouzis MV. Vallilas C, et al. Among authors: karamouzis mv. Int J Mol Sci. 2021 Jan 6;22(2):493. doi: 10.3390/ijms22020493. Int J Mol Sci. 2021. PMID: 33419029 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page